YCW23· OtherInvitris
Creating new protein-based drugs at scale
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Competitors
Closest in what they build, same category.
Talus BioS21Discovering drugs that target the DNA regulomeShared: biotech, drug discoveryActive
Notable LabsW15Personalized drug discovery for blood cancer.Shared: biotech, drug discoveryPublic
SynsoryBioW24"If-then" conditional logic for protein drugsShared: biotechActive
EpinomaS21We engineer proteins that control the operating system of biology.Shared: biotechActive
Adjacent
Overlapping tags, a different niche.
Harmonic DiscoveryS21Multi-targeted therapeutics to treat complex diseasesShared: biotech, drug discoveryActive
Lavo Life SciencesW23AI for drug formulationShared: biotech, drug discoveryInactive
Arpeggio BioS19Arpeggio Bio develops drugs targeting transcription factors using AI…Shared: biotech, drug discoveryActive
Numerion LabsW15Artificial intelligence for drug discovery.Shared: biotech, drug discoveryActive
General ProximityW20The next generation of induced-proximity medicines.Shared: biotech, drug discoveryActive
Also from W23
Batchmates in Winter 2023.
Diffuse BioW23Generative AI for protein designActive
Pando BioscienceW23Gen-AI Designed Enzymes for Pharmaceutical InnovationActive
Persist AIW23Developing long-lasting drug formulations 50% fasterActive
1stCollabW23Performance-Optimized Influencer Marketing at ScaleActive
222W23the AI social facilitator for offline human to human interactionsActive
Adri AIW23Your AI Partner for SAP DevelopmentActive
About Invitris
Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.
Munich, BY, Germany
Invitris: questions
Which YC batch was Invitris in?
Invitris was in Y Combinator's Winter 2023 batch (W23).
Is Invitris still active?
Y Combinator lists Invitris as active.
Where is Invitris based?
Invitris lists Munich, BY, Germany as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.